Low-dose treatment with sulfonylureas improves hyperglucagonemia after a glucose challenge in HNF1A-MODY individuals and Hnf1a(-/-) mice
Saponaro C., Spiliotis I., Acosta-Montalvo A., Anguelova L., Thevenet J., Chiral M., Gmyr V., Kerr-Conte J., Pattou F., Pontoglio M., Owen KR., Bonner C.